Legis Daily

International Pharmaceutical Supply Chain Security Agreement Act of 2021

USA117th CongressHR-4711| House 
| Updated: 7/27/2021
John Joyce

John Joyce

Republican Representative

Pennsylvania

Cosponsors (1)
Jim Banks (Republican)

Ways and Means Committee, Rules Committee, Trade Subcommittee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
International Pharmaceutical Supply Chain Security Agreement Act of 2021 This bill establishes principal trade negotiating objectives of the United States with respect to pharmaceutical products, including objectives regarding subsidies and government procurement. It also extends through July 1, 2023 (or July 1, 2026, if the President receives an extension) the authority of the President to enter into trade agreements with foreign countries.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 27, 2021
Introduced in House
Jul 27, 2021
Referred to the Subcommittee on Trade.
Jul 27, 2021
Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • July 27, 2021
    Introduced in House
  • July 27, 2021
    Referred to the Subcommittee on Trade.
  • July 27, 2021
    Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Foreign Trade and International Finance

Related Bills

  • HR 117-4792: Countering Communist China Act

International Pharmaceutical Supply Chain Security Agreement Act of 2021

USA117th CongressHR-4711| House 
| Updated: 7/27/2021
International Pharmaceutical Supply Chain Security Agreement Act of 2021 This bill establishes principal trade negotiating objectives of the United States with respect to pharmaceutical products, including objectives regarding subsidies and government procurement. It also extends through July 1, 2023 (or July 1, 2026, if the President receives an extension) the authority of the President to enter into trade agreements with foreign countries.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 27, 2021
Introduced in House
Jul 27, 2021
Referred to the Subcommittee on Trade.
Jul 27, 2021
Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • July 27, 2021
    Introduced in House
  • July 27, 2021
    Referred to the Subcommittee on Trade.
  • July 27, 2021
    Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
John Joyce

John Joyce

Republican Representative

Pennsylvania

Cosponsors (1)
Jim Banks (Republican)

Ways and Means Committee, Rules Committee, Trade Subcommittee

Foreign Trade and International Finance

Related Bills

  • HR 117-4792: Countering Communist China Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted